Literature DB >> 25633721

[The role of the innate immune system in atopic dermatitis].

T Volz1, S Kaesler, Y Skabytska, T Biedermann.   

Abstract

The mechanisms how the innate immune system detects microbes and mounts a rapid immune response have been more and more elucidated in the past years. Subsequently it has been shown that innate immunity also shapes adaptive immune responses and determines their quality that can be either inflammatory or tolerogenic. As atopic dermatitis is characterized by disturbances of innate and adaptive immune responses, colonization with pathogens and defects in skin barrier function, insight into mechanisms of innate immunity has helped to understand the vicious circle of ongoing skin inflammation seen in atopic dermatitis patients. Elucidating general mechanisms of the innate immune system and its functions in atopic dermatitis paves the way for developing new therapies. Especially the novel insights into the human microbiome and potential functional consequences make the innate immune system a very fundamental and promising target. As a result atopic dermatitis manifestations can be attenuated or even resolved. These currently developed strategies will be introduced in the current review.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25633721     DOI: 10.1007/s00105-014-3563-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  28 in total

Review 1.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 2.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells.

Authors:  Yuliya Skabytska; Florian Wölbing; Claudia Günther; Martin Köberle; Susanne Kaesler; Ko-Ming Chen; Emmanuella Guenova; Doruk Demircioglu; Wolfgang E Kempf; Thomas Volz; Hans-Georg Rammensee; Martin Schaller; Martin Röcken; Friedrich Götz; Tilo Biedermann
Journal:  Immunity       Date:  2014-11-13       Impact factor: 31.745

4.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Authors:  Peck Y Ong; Takaaki Ohtake; Corinne Brandt; Ian Strickland; Mark Boguniewicz; Tomas Ganz; Richard L Gallo; Donald Y M Leung
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

Review 5.  The regulation of IL-10 production by immune cells.

Authors:  Margarida Saraiva; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2010-02-15       Impact factor: 53.106

6.  Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo.

Authors:  Siegbert Rieg; Heiko Steffen; Silke Seeber; Andreas Humeny; Hubert Kalbacher; Klaus Dietz; Claus Garbe; Birgit Schittek
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

Review 7.  Recognition of Staphylococcus aureus by the innate immune system.

Authors:  Bénédicte Fournier; Dana J Philpott
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

8.  Signaling organelles of the innate immune system.

Authors:  Jonathan C Kagan
Journal:  Cell       Date:  2012-12-07       Impact factor: 41.582

9.  Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus.

Authors:  Michael D Howell; Richard L Gallo; Mark Boguniewicz; James F Jones; Cathy Wong; Joanne E Streib; Donald Y M Leung
Journal:  Immunity       Date:  2006-03       Impact factor: 31.745

10.  Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study.

Authors:  A Gueniche; B Knaudt; E Schuck; T Volz; P Bastien; R Martin; M Röcken; L Breton; T Biedermann
Journal:  Br J Dermatol       Date:  2008-09-15       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.